TABLE 6

Effects of MK-801 alone and MK-801 combined with JWS-USC-75-IX on latencies, omissions, and trials completed in the standard version of the 5C-SRTT (0.5-s stimulus duration; n = 12)

Data are presented as mean ± S.E.M. The MK-801 dose was 0.05 mg/kg.

Treatment	Latency			Omissions	Trials Completed
Treatment	Correct	Incorrect	Magazine	Omissions	Trials Completed
	s			%
Vehicle + vehicle	0.71 ± 0.04	1.72 ± 0.07	1.56 ± 0.10	5.06 ± 2.19	99.70 ± 0.16
Vehicle + MK-801	0.68 ± 0.03	1.56 ± 0.16	1.10 ± 0.16^*	7.90 ± 0.86	71.50 ± 6.64^*
JWS-USC-75-IX (0.1 mg/kg) + MK-801	0.66 ± 0.02	1.84 ± 0.16	1.07 ± 0.05^*	6.70 ± 1.63	87.08 ± 4.55^†
JWS-USC-75-IX (0.3 mg/kg) + MK-801	0.70 ± 0.04	1.72 ± 0.21	1.22 ± 0.13^*	6.21 ± 1.44	92.83 ± 5.09^†
JWS-USC-75-IX (1.0 mg/kg) + MK-801	0.69 ± 0.03	1.48 ± 0.17	1.05 ± 0.05^*	6.04 ± 1.41	85.88 ± 4.57^†

↵* p < 0.05, statistically significant difference from vehicle-treated group.
↵† p < 0.05, statistically significant difference from the vehicle-MK-801-treated group.